Naloxone Training for Opioid Overdose
Trial Summary
What is the purpose of this trial?
The pervasive impact of the opioid epidemic has touched all layers of society for the past two decades, resulting in over 115 deaths daily and imposing annual costs of $78.5 billion. Responding swiftly to overdoses, akin to various medical emergencies, poses a significant challenge, particularly in geographically dispersed rural areas and densely populated urban settings. Effectively delivering the life-saving drug naloxone, which counteracts the effects of overdoses, necessitates a well-coordinated and cost-efficient response system. Simply opting for widespread distribution of naloxone, even with citizen involvement, proves to be a financially burdensome approach when compared to more targeted strategies. Moreover, obstacles such as limited access, inadequate or unavailable naloxone training, and delayed response times from emergency responders compound the problem. Addressing these issues, the proposed Opioid Rapid Response System (ORRS) project seeks to advance prevention science by adopting an innovative approach that incorporates technology and contemporary communication theory. The primary objective of the ORRS project is to mitigate opioid overdose deaths by enlisting and training citizens to administer naloxone in response to such events. Leveraging the PulsePoint health app, which connects citizens to cardiac events, the ORRS project will extend its capabilities to respond to overdose incidents. This initiative involves comprehensive development of ORRS, followed by a randomized clinical trial on a national scale to assess its effectiveness. The study aims to contribute to both prevention and implementation science by identifying optimal recruitment strategies and testing a model of online training. In pursuit of these objectives, the study is guided by the following Specific Aims: SA 1: Refine and complete the development of ORRS. SA 2: Conduct a randomized clinical trial to evaluate the effectiveness of the intervention. SA 3: Prepare ORRS for dissemination.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of this treatment for opioid overdose?
Research shows that training people, including healthcare professionals and nonmedical personnel, on how to use naloxone (a drug that can reverse opioid overdoses) increases their knowledge and confidence in managing overdoses. This training has been effective in various settings, helping to prevent deaths from opioid overdoses.12345
Is naloxone training safe for humans?
Naloxone training programs have been widely implemented to help prevent opioid overdose deaths, and there is no evidence suggesting that these training programs are unsafe for participants. The focus of these programs is on education and skill-building, which are generally considered safe activities.45678
How is the Naloxone Training for Opioid Overdose treatment different from other treatments for opioid overdose?
This treatment is unique because it focuses on training individuals, including healthcare professionals and community members, to effectively respond to opioid overdoses using naloxone, a medication that can reverse the effects of an overdose. Unlike other treatments that may focus solely on medication administration, this approach emphasizes education and skill-building to empower more people to act in emergency situations.1491011
Research Team
Hye Jeong Choi
Principal Investigator
Univeristy of Missouri
Michael Hecht
Principal Investigator
Real Prevention
Eligibility Criteria
This trial is for adults over 18 who live in communities using the PulsePoint app, speak English fluently, and can download and use apps on a smartphone. It's not suitable for those who don't meet these criteria.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Development
Refine and complete the development of the Opioid Rapid Response System (ORRS)
Training
Participants receive online Naloxone training or non-active opioid overdose response training
Follow-up
Participants are monitored for their intent to intervene, self-efficacy, response efficacy, knowledge, and concerns related to opioid overdose management
Treatment Details
Interventions
- Non-active opioid overdose response training
- Opioid Rapid Response System (ORRS) training
Non-active opioid overdose response training is already approved in United States, European Union, Canada for the following indications:
- Reversal of opioid overdose
- Reversal of opioid overdose
- Reversal of opioid overdose
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri-Columbia
Lead Sponsor